Abstract
Background: Few therapies are effective for preventing cluster headache. Naratriptan, a 5-hydroxytryptamine1B/D (5-HT1B/D)-agonist, appears effective as a pharmacotherapy for migraine. There have been few reports whether naratriptan could reduce the frequency of cluster headache attacks.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
